Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma.
10.1007/s12264-023-01082-1
- Author:
Bo NI
1
;
Yiqing YIN
2
;
Zekun LI
1
;
Junjin WANG
1
;
Xiuchao WANG
3
;
Kaiyuan WANG
4
Author Information
1. Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
2. Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
3. Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. wangxiuchao2008@163.com.
4. Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. kywang@tmu.edu.cn.
- Publication Type:Review
- Keywords:
Cancer-neuroscience;
PDAC;
Pain;
Peripheral innervation
- MeSH:
Humans;
Carcinoma, Pancreatic Ductal/pathology*;
Pancreatic Neoplasms/therapy*;
Signal Transduction;
Peripheral Nerves/metabolism*;
Tumor Microenvironment
- From:
Neuroscience Bulletin
2023;39(11):1717-1731
- CountryChina
- Language:English
-
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive lethal malignancy, characterized by late diagnosis, aggressive growth, and therapy resistance, leading to a poor overall prognosis. Emerging evidence shows that the peripheral nerve is an important non-tumor component in the tumor microenvironment that regulates tumor growth and immune escape. The crosstalk between the neuronal system and PDAC has become a hot research topic that may provide novel mechanisms underlying tumor progression and further uncover promising therapeutic targets. In this review, we highlight the mechanisms of perineural invasion and the role of various types of tumor innervation in the progression of PDAC, summarize the potential signaling pathways modulating the neuronal-cancer interaction, and discuss the current and future therapeutic possibilities for this condition.
